SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-104406
Filing Date
2022-04-13
Accepted
2022-04-13 16:57:01
Documents
13
Period of Report
2022-04-11
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d311870d8k.htm   iXBRL 8-K 25330
  Complete submission text file 0001193125-22-104406.txt   174026

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA me-20220411.xsd EX-101.SCH 3220
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE me-20220411_def.xml EX-101.DEF 12915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE me-20220411_lab.xml EX-101.LAB 21162
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE me-20220411_pre.xml EX-101.PRE 13651
7 EXTRACTED XBRL INSTANCE DOCUMENT d311870d8k_htm.xml XML 4689
Mailing Address 223 NORTH MATHILDA AVENUE SUNNYVALE CA 94086
Business Address 223 NORTH MATHILDA AVENUE SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 22825221
SIC: 2834 Pharmaceutical Preparations